Evidence map›Paper›PMID 34028177›Full record

ReviewJournal of cellular and molecular medicine2021

The role of SIRT2 in vascular-related and heart-related diseases: A review.

Boquan Wu, Shilong You, Hao Qian, Shaojun Wu, Saien Lu, Ying Zhang, Yingxian Sun, Naijin Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Emerging Theranostic Nanomaterials in Diabetes and Its Complications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Boquan WuDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.ORCID 0000-0002-4242-2821
Shilong YouDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.ORCID 0000-0001-8327-1030
Hao QianDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Shaojun WuDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Saien LuDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Ying ZhangDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Yingxian SunDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.
Naijin ZhangDepartment of Cardiology, The First Hospital of China Medical University, Shenyang, China.ORCID 0000-0003-3653-9801
First Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, cardiovascular disease is one of the important factors of human death, and there are many kinds of proteins involved. Sirtuins family proteins are involved in various physiological and pathological activities of the human body. Among them, there are more and more studies on the relationship between sirtuin2 (SIRT2) protein and cardiovascular diseases. SIRT2 can effectively inhibit pathological cardiac hypertrophy. The effect of SIRT2 on ischaemia-reperfusion injury has different effects under different conditions. SIRT2 can reduce the level of reactive oxygen species (ROS), which may help to reduce the severity of diabetic cardiomyopathy. SIRT2 can affect a variety of cardiovascular diseases, energy metabolism and the ageing of cardiomyocytes, thereby affecting heart failure. SIRT2 also plays an important role in vascular disease. For endothelial cell damage used by oxidative stress, the role of SIRT2 is bidirectional, which is related to the degree of oxidative stress stimulation. When the degree of stimulation is small, SIRT2 plays a protective role, and when the degree of stimulation increases to a certain level, SIRT2 plays a negative role. In addition, SIRT2 is also involved in the remodelling of blood vessels and the repair of skin damage.

Indexed as

AgingCardiovascular DiseasesEnergy MetabolismHumansOxidative StressReactive Oxygen SpeciesReperfusion InjurySirtuin 2SkinReactive Oxygen SpeciesSIRT2 protein, humanSirtuin 2diabetic cardiomyopathyheart failureischaemia-reperfusion injuryoxidative stresspathological cardiac hypertrophySIRT2

Identifiers

PMID34028177
PMCPMC8278089
OpenAlexW3165133141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.